HLA-DRB1 and myeloid sarcoma: First of all, candidate gene studies have assessed the role of genes implicated in MS susceptibility in determining disease course, failing to identify any significant association (Jensen et al., 2010) except for the HLA-DRB1*1501 allele (Hauser et al., 2000; Barcellos et al., 2003).